
Biomarker types and colorectal cancer

Biomarkers 101
Learn the basics about biomarkers and colorectal cancer, why testing is important, and what learning about your biomarker mutations can mean for your treatment options and cancer outcomes.

Biomarker type resource guide
This resource grid details the different types of biomarkers and how they relate to a colorectal cancer diagnosis and treatment.

The Alliance’s personalized treatment program
The Alliance and Perthera have partnered to provide personalized treatment options to stage III and IV patients with colorectal cancer.
If you recently had molecular/biomarker testing, your results will be analyzed with no additional testing required.
Call us at the Alliance’s Helpline at (877) 422-2030 to enroll.
Related reading
SidednessTop resources

Supreme Court to rule on preventive CRC screening
An unfavorable ruling by the court could undermine screening prevention, allowing insurers to charge patients for potentially lifesaving services.

Alliance Survey Reveals Disparities in Minorities that Could Increase Colorectal Cancer Risk
Minority groups are significantly less aware that colorectal cancer is often not detected until the late stages due to mild symptoms.

Lexie Haglund: Beating stage IV CRC
Discover how knowing her G12C biomarker guided Lexie’s stage IV colorectal cancer treatment — from a shock diagnosis to HIPEC surgery — and why screening, research, and self-advocacy matter.